home / stock / hltrf / hltrf quote
Last: | $2.59 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $2.59 |
High: | $0 |
Low: | $0 |
Volume: | 100 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.59 | $0 | $2.59 | $0 | $0 | 100 | 07-16-2024 |
$2.59 | $0 | $2.59 | $0 | $0 | 200 | 07-15-2024 |
$2.59 | $2.59 | $2.59 | $2.59 | $2.59 | 200 | 07-12-2024 |
$2.59 | $0 | $2.59 | $0 | $0 | 100 | 07-10-2024 |
$2.59 | $0 | $2.59 | $0 | $0 | 100 | 07-09-2024 |
$2.59 | $2.59 | $2.59 | $2.59 | $2.59 | 100 | 07-04-2024 |
$2.59 | $2.59 | $2.59 | $2.59 | $2.59 | 100 | 07-03-2024 |
$2.45 | $2.45 | $2.45 | $2.45 | $2.45 | 100 | 06-28-2024 |
$2.46 | $0 | $2.46 | $0 | $0 | 2 | 06-26-2024 |
$2.46 | $0 | $2.46 | $0 | $0 | 100 | 06-24-2024 |
$2.46 | $0 | $2.46 | $0 | $0 | 200 | 06-21-2024 |
$2.46 | $2.46 | $2.46 | $2.46 | $2.46 | 300 | 06-20-2024 |
$2.47 | $2.47 | $2.47 | $2.47 | $2.47 | 102 | 06-17-2024 |
$2.79 | $0 | $2.79 | $0 | $0 | 100 | 06-12-2024 |
$2.79 | $0 | $2.79 | $0 | $0 | 200 | 06-11-2024 |
$2.79 | $2.79 | $2.79 | $2.79 | $2.79 | 700 | 06-04-2024 |
$2.9 | $0 | $2.9 | $0 | $0 | 100 | 05-30-2024 |
$2.9 | $2.75 | $2.9 | $2.9 | $2.75 | 200 | 05-29-2024 |
$2.92 | $2.92 | $2.92 | $2.92 | $2.92 | 500 | 05-17-2024 |
$2.9 | $2.9 | $2.9 | $2.9 | $2.9 | 2,400 | 05-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc Company Name:
HLTRF Stock Symbol:
OTCMKTS Market:
HLS Therapeutics Inc Website:
HLS Therapeutics Announces First Quarter Fiscal 2021 Financial Results Canada NewsWire Q1 2021 revenue of $14.3 million , Adjusted EBITDA of $6.7 million and cash from operations of $7.2 million , up $0.4 million , $0.6 million and $1.8 million ...
HLS Therapeutics to Host Q1 2021 Financial Results Conference Call Canada NewsWire TORONTO , April 22, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 2021 financial results on Thursday, May 6, 2021 ...
HLS Therapeutics Announces Participation in Upcoming Conferences Canada NewsWire TORONTO , April 15, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular ma...